Pharmacy Week in Review: March 16, 2018

Most Popular

Related Articles

Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.
Excelera has announced the appointment of Lorrie A. Carr as its new CEO. Ms. Carr succeeds Jim Fox who retired effective April 2.
Targeting the right pathways in inflammatory bowel disease (IBD) and providing the right medication for the pathways involved can have significant effects on outcomes for patients with this condition. There is a wide range of pharmacologic agents in the treatment of IBD and research indicates that there is a need to educate specialty pharmacists about this range of current and emerging pharmacologic treatments, as well as the best manner in developing a benefits design strategy which can minimize the economic burden of the disease.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$